General Atlantic-backed Rubicon Research to launch Rs 1,377.5-crore IPO on October 9
Rubicon Research, a General Atlantic-promoted pharma company, is all set to launch its Rs 1,377.5-crore initial public offering (IPO) on October 9, joining the wave of major public issues next week alongside Tata Capital’s Rs 15,512-crore IPO and LG Electronics India’s Rs 11,607-crore offering. The anchor book for the IPO will open for a single…